Search for a doctor

Doug W. Challener, M.D., M.S.

Publications

  1. Yetmar ZA, Khodadadi RB, Chesdachai S, McHugh JW, Challener DW, Wengenack NL, Bosch W, Seville MT, Beam E. Epidemiology, Timing, and Secondary Prophylaxis of Recurrent Nocardiosis. Open Forum Infect Dis. 2024 Apr; 11 (4):ofae122 Epub 2024 Mar 01
    View PubMed
  2. Yetmar ZA, Chesdachai S, Khodadadi RB, McHugh JW, Challener DW, Wengenack NL, Bosch W, Seville MT, Beam E. Outcomes of transplant recipients with pretransplant Nocardia colonization or infection. Transpl Infect Dis. 2023 Oct; 25 (5):e14097 Epub 2023 June 28
    View PubMed
  3. Yetmar ZA, Chesdachai S, Duffy D, Smith BH, Challener DW, Seville MT, Bosch W, Beam E. Risk factors and prophylaxis for nocardiosis in solid organ transplant recipients: A nested case-control study. Clin Transplant. 2023 Sep; 37 (9):e15016 Epub 2023 May 11
    View PubMed
  4. Yetmar ZA, Khodadadi RB, Chesdachai S, McHugh JW, Challener DW, Wengenack NL, Bosch W, Seville MT, Beam E. Mortality After Nocardiosis: Risk Factors and Evaluation of Disseminated Infection. Open Forum Infect Dis. 2023 Aug; 10 (8):ofad409 Epub 2023 Aug 01
    View PubMed
  5. Chesdachai S, Baddour LM, Sohail MR, Palraj BR, Madhavan M, Tabaja H, Fida M, Challener DW, DeSimone DC. Candidemia in Patients With Cardiovascular Implantable Electronic Devices: Uncertainty in Management Based on Current International Guidelines. Open Forum Infect Dis. 2023 Jul; 10 (7):ofad318 Epub 2023 June 13
    View PubMed
  6. Yetmar ZA, Chesdachai S, Lahr BD, Challener DW, Arensman Hannan KN, Epps K, Stevens RW, Seville MT, Tande AJ, Virk A. Comparison of Oral and Intravenous Definitive Antibiotic Therapy for Beta-Hemolytic Streptococcus Species Bloodstream Infections from Soft Tissue Sources: a Propensity Score-Matched Analysis. Antimicrob Agents Chemother. 2023 Jun 15; 67 (6):e0012023 Epub 2023 May 16
    View PubMed
  7. Challener DW, Gao X, Tehranian S, Kashani KB, O'Horo JC. Body temperature and infection in critically ill patients on continuous kidney replacement therapy. BMC Nephrol. 2023 Jun 7; 24 (1):161 Epub 2023 June 07
    View PubMed
  8. Yetmar ZA, Challener DW, Seville MT, Bosch W, Beam E. Outcomes of Nocardiosis and Treatment of Disseminated Infection in Solid Organ Transplant Recipients. Transplantation. 2023 Mar 1; 107 (3):782-791 Epub 2022 Oct 28
    View PubMed
  9. Ranganath N, Shirley JD, Challener DW, Stevens RW, Kind DR, Comba IY, Patel R, Schuetz AN, Shah AS. Leptotrichia Bacteremia: 10-Year Retrospective Clinical Analysis and Antimicrobial Susceptibility Profiles. J Clin Microbiol. 2023 Feb 22; 61 (2):e0173322 Epub 2023 Jan 30
    View PubMed
  10. Ranganath N, O'Horo JC, Challener DW, Tulledge-Scheitel SM, Pike ML, O'Brien M, Razonable RR, Shah A. Rebound Phenomenon After Nirmatrelvir/Ritonavir Treatment of Coronavirus Disease 2019 (COVID-19) in High-Risk Persons. Clin Infect Dis. 2023 Feb 8; 76 (3):e537-e539
    View PubMed
  11. Challener D, O'Horo J, Tande AJ. Infectious disease physician characteristics and prescription of meropenem in the hospital. Antimicrob Steward Healthc Epidemiol. 2023; 3 (1):e126 Epub 2023 July 17
    View PubMed
  12. Challener D, Frank R, Kashani K, O'Horo J. Body temperature trends of critically Ill patients on continuous renal replacement therapy: A single-center retrospective study. Am J Med Sci. 2022 Oct; 364 (4):404-408 Epub 2022 Apr 20
    View PubMed
  13. Razonable RR, O'Horo JC, Challener DW, Arndt L, Arndt RF, Clune CG, Culbertson TL, Hall ST, Heyliger A, Jackson TA, Kennedy BD, Larsen J, Hanson SN, Sweeten PW, Tulledge-Scheitel SM, Ganesh R. Curbing the Delta Surge: Clinical Outcomes After Treatment With Bamlanivimab-Etesevimab, Casirivimab-Imdevimab, or Sotrovimab for Mild to Moderate Coronavirus Disease 2019. Mayo Clin Proc. 2022 Sep; 97 (9):1641-1648 Epub 2022 June 23
    View PubMed
  14. Tande AJ, Swift MD, Challener DW, Berbari EF, Tommaso CP, Christopherson DR, Binnicker MJ, Breeher LE. Utility of Follow-up Coronavirus Disease 2019 (COVID-19) Antigen Tests After Acute Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Healthcare Personnel. Clin Infect Dis. 2022 Aug 24; 75 (1):e347-e349
    View PubMed
  15. Comba IY, Riestra Guiance I, Corsini Campioli C, Challener D, Sampathkumar P, Orenstein R, Gordon J, Bosch W, O'Horo JC. Clinical Characteristics and Outcomes of Patients With SARS-CoV-2 Reinfection. Mayo Clin Proc Innov Qual Outcomes. 2022 Aug; 6 (4):361-372 Epub 2022 May 30
    View PubMed
  16. Pawlowski C, Silvert E, O'Horo JC, Lenehan PJ, Challener D, Gnass E, Murugadoss K, Ross J, Speicher L, Geyer H, Venkatakrishnan AJ, Badley AD, Soundararajan V. SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomes. PNAS Nexus. 2022 Jul; 1 (3):pgac071 Epub 2022 July 04
    View PubMed
  17. O'Horo J, Challener DW, Anderson RJ, Arndt RF, Ausman SE, Hall ST, Heyliger A, Kennedy BD, Sweeten PW, Ganesh R, Razonable RR. Rates of Severe Outcomes After Bamlanivimab-Etesevimab and Casirivimab-Imdevimab Treatment of High-Risk Patients With Mild to Moderate Coronavirus Disease 2019. Mayo Clin Proc. 2022 May; 97 (5):943-950 Epub 2022 Feb 23
    View PubMed
  18. Puranik A, Lenehan PJ, O'Horo JC, Pawlowski C, Virk A, Swift MD, Kremers W, Venkatakrishnan AJ, Challener DW, Breeher L, Gordon JE, Geyer HL, Speicher LL, Soundararajan V, Badley AD. Durability analysis of the highly effective mRNA-1273 vaccine against COVID-19. PNAS Nexus. 2022 May; 1 (2):pgac058 Epub 2022 May 20
    View PubMed
  19. Niesen MJM, Matson R, Puranik A, O'Horo JC, Pawlowski C, Vachon C, Challener D, Virk A, Swift M, Speicher L, Gordon J, Geyer H, Lenehan PJ, Venkatakrishnan AJ, Soundararajan V, Badley A. Third dose vaccination with mRNA-1273 or BNT162b2 vaccines improves protection against SARS-CoV-2 infection. PNAS Nexus. 2022 May; 1 (2):pgac042 Epub 2022 Apr 28
    View PubMed
  20. Niesen MJM, Pawlowski C, O'Horo J, Challener DW, Silvert E, Donadio G, Lenehan PJ, Virk A, Swift MD, Speicher L, Gordon JE, Geyer H, Halamka J, Venkatakrishnan AJ, Soundararajan V, Badley AD. Three doses of COVID-19 mRNA vaccination are safe based on adverse events reported in electronic health records Journal of the American Medical Association (JAMA) Network Open. 2022.
  21. Chesdachai S, Yetmar ZA, Tabaja H, Comba IY, Go JR, Challener DW, Misra A, Abu Saleh OM. Contemporary experience of Abiotrophia, Granulicatella and Gemella bacteremia. J Infect. 2022 Apr; 84 (4):511-517 Epub 2022 Feb 01
    View PubMed
  22. Niesen MJM, Pawlowski C, O'Horo JC, Challener DW, Silvert E, Donadio G, Lenehan PJ, Virk A, Swift MD, Speicher LL, Gordon JE, Geyer HL, Halamka JD, Venkatakrishnan AJ, Soundararajan V, Badley AD. Surveillance of Safety of 3 Doses of COVID-19 mRNA Vaccination Using Electronic Health Records. JAMA Netw Open. 2022 Apr 1; 5 (4):e227038 Epub 2022 Apr 01
    View PubMed
  23. O'Horo JC, Challener DW, Speicher L, Bosch W, Seville MT, Bierle DM, Ganesh R, Wilker CG, Arndt RF, Arndt LL, Tulledge-Scheitel SM, Hanson SN, Razonable RR. Effectiveness of Monoclonal Antibodies in Preventing Severe COVID-19 With Emergence of the Delta Variant. Mayo Clin Proc. 2022 Feb; 97 (2):327-332 Epub 2021 Dec 16
    View PubMed
  24. Go JR, Challener D, Corsini Campioli C, Sohail MR, Palraj R, Baddour LM, Abu Saleh O. Clinical Significance of Staphylococcus aureus in a Single Positive Blood Culture Bottle. Open Forum Infect Dis. 2022 Feb; 9 (2):ofab642 Epub 2021 Dec 18
    View PubMed
  25. Corsini Campioli C, Challener D, Comba IY, Shah A, Wilson WR, Sohail MR, Van Gompel JJ, O'Horo JC. Overview and risk factors for postcraniotomy surgical site infection: A four-year experience. Antimicrob Steward Healthc Epidemiol. 2022; 2 (1):e14 Epub 2022 Jan 31
    View PubMed
  26. Tande AJ, Swift MD, Challener DW, Berbari EF, Tommaso CP, Christopherson DR, Binnicker MJ, Breeher LE. Utility of follow-up coronavirus disease 2019 (COVID-19) antigen tests after acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among healthcare personnel. Clinical Infectious Diseases. 2022; 75 (1):e347-9
  27. Fida M, Khalil S, Abu Saleh O, Challener DW, Sohail MR, Yang JN, Pritt BS, Schuetz AN, Patel R. Diagnostic Value of 16S Ribosomal RNA Gene Polymerase Chain Reaction/Sanger Sequencing in Clinical Practice. Clin Infect Dis. 2021 Sep 15; 73 (6):961-968
    View PubMed
  28. Pennington KM, Vu A, Challener D, Rivera CG, Shweta FNU, Zeuli JD, Temesgen Z. Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease. J Clin Tuberc Other Mycobact Dis. 2021 Aug; 24:100244 Epub 2021 May 08
    View PubMed
  29. Shah A, Challener DW, O'Horo JC, Badley AD. Vaccination Safety: Don't Toss the Champagne With the Cork. Mayo Clin Proc. 2021 Jul; 96 (7):1712-1713
    View PubMed
  30. Corsini Campioli C, Castillo Almeida NE, O'Horo JC, Challener D, Go JR, DeSimone DC, Sohail MR. Clinical Presentation, Management, and Outcomes of Patients With Brain Abscess due to Nocardia Species. Open Forum Infect Dis. 2021 Apr; 8 (4):ofab067 Epub 2021 Apr 07
    View PubMed
  31. Yetmar ZA, Challener DW, Tleyjeh IM, Sohail MR, Cerhan JR, Badley AD, O'Horo JC. Association Between Chronic Statin Use and 30-Day Mortality in Hospitalized Patients With COVID-19. Mayo Clin Proc Innov Qual Outcomes. 2021 Apr; 5 (2):442-446 Epub 2021 Mar 14
    View PubMed
  32. Challener DW, Breeher LE, Frain J, Swift MD, Tosh PK, O'Horo J. Healthcare personnel absenteeism, presenteeism, and staffing challenges during epidemics. Infect Control Hosp Epidemiol. 2021 Apr; 42 (4):388-391 Epub 2020 Oct 26
    View PubMed
  33. Corsini Campioli C, Go JR, Abu Saleh O, Challener D, Yetmar Z, Osmon DR. Antistaphylococcal Penicillin vs Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Spinal Epidural Abscesses. Open Forum Infect Dis. 2021 Mar; 8 (3):ofab071 Epub 2021 Feb 16
    View PubMed
  34. O'Horo JC, Cerhan JR, Cahn EJ, Bauer PR, Temesgen Z, Ebbert J, Abril A, Abu Saleh OM, Assi M, Berbari EF, Bierle DM, Bosch W, Burger CD, Cano Cevallos EJ, Clements CM, Carmona Porquera EM, Castillo Almeida NE, Challener DW, Chesdachai S, Comba IY, Corsini Campioli CG, Crane SJ, Dababneh AS, Enzler MJ, Fadel HJ, Ganesh R, De Moraes AG, Go JR, Gordon JE, Gurram PR, Guru PK, Halverson EL, Harrison MF, Heaton HA, Hurt R, Kasten MJ, Lee AS, Levy ER, Libertin CR, Mallea JM, Marshall WF 3rd, Matcha G, Meehan AM, Franco PM, Morice WG 2nd, O'Brien JJ, Oeckler R, Ommen S, Oravec CP, Orenstein R, Ough NJ, Palraj R, Patel BM, Pureza VS, Pickering B, Phelan DM, Razonable RR, Rizza S, Sampathkumar P, Sanghavi DK, Sen A, Siegel JL, Singbartl K, Shah AS, Shweta F, Speicher LL, Suh G, Tabaja H Jr, Tande A, Ting HH, Tontz RC 3rd, Vaillant JJ, Vergidis P, Warsame MY, Yetmar ZA, Zomok CCD, Williams AW, Badley AD. Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research. Mayo Clin Proc. 2021 Mar; 96 (3):601-618 Epub 2020 Dec 26
    View PubMed
  35. Eberly AR, Challener DW, Shweta FNU, Fida M, Boerger AC, Assi M, O'Horo JC, Binnicker MJ. Initial SARS-CoV-2 PCR crossing point does not predict hospitalization and duration of PCR positivity. J Microbiol Immunol Infect. 2021 Feb; 54 (1):77-80 Epub 2020 Oct 10
    View PubMed
  36. Agarwal V, Venkatakrishnan AJ, Puranik A, Kirkup C, Lopez-Marquez A, Challener DW, Theel ES, O'Horo JC, Binnicker MJ, Kremers WK, Faubion WA Jr, Badley AD, Williams AW, Gores GJ, Halamka JD, Morice WG 2nd, Soundararajan V. Long-term SARS-CoV-2 RNA shedding and its temporal association to IgG seropositivity. Cell Death Discov. 2020 Dec 2; 6 (1):138 Epub 2020 Dec 02
    View PubMed
  37. Challener DW, Shah A, O'Horo JC, Berbari E, Binnicker MJ, Tande AJ. Low Utility of Repeat Real-Time PCR Testing for SARS-CoV-2 in Clinical Specimens. Mayo Clin Proc. 2020 Sep; 95 (9):1942-1945 Epub 2020 July 04
    View PubMed
  38. Challener DW, Dowdy SC, O'Horo JC. Analytics and Prediction Modeling During the COVID-19 Pandemic. Mayo Clin Proc. 2020 Sep; 95 (9S):S8-S10 Epub 2020 June 22
    View PubMed
  39. Tande AJ, Challener DW, Shah AS, O'Horo JC, Beam E. Community-Based Drive-Through and Walk-Through Testing Centers. Mayo Clin Proc. 2020 Sep; 95 (9S):S20-S22 Epub 2020 June 30
    View PubMed
  40. Shah AS, Tande AJ, Challener DW, O'Horo JC, Binnicker MJ, Berbari EF. Diagnostic Stewardship: An Essential Element in a Rapidly Evolving COVID-19 Pandemic. Mayo Clin Proc. 2020 Sep; 95 (9S):S17-S19 Epub 2020 June 23
    View PubMed
  41. Challener DW, Challener GJ, Gow-Lee VJ, Fida M, Shah AS, O'Horo JC. Screening for COVID-19: Patient factors predicting positive PCR test. Infect Control Hosp Epidemiol. 2020 Aug; 41 (8):968-969 Epub 2020 May 19
    View PubMed
  42. Wagner T, Shweta F, Murugadoss K, Awasthi S, Venkatakrishnan AJ, Bade S, Puranik A, Kang M, Pickering BW, O'Horo JC, Bauer PR, Razonable RR, Vergidis P, Temesgen Z, Rizza S, Mahmood M, Wilson WR, Challener D, Anand P, Liebers M, Doctor Z, Silvert E, Solomon H, Anand A, Barve R, Gores G, Williams AW, Morice WG 2nd, Halamka J, Badley A, Soundararajan V. Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis. Elife. 2020 Jul 7; 9 Epub 2020 July 07
    View PubMed
  43. Shah A, Challener D, Tande AJ, Mahmood M, O'Horo JC, Berbari E, Crane SJ. Drive-Through Testing: A Unique, Efficient Method of Collecting Large Volume of Specimens During the SARS-CoV-2 (COVID-19) Pandemic. Mayo Clin Proc. 2020 Jul; 95 (7):1420-1425 Epub 2020 May 01
    View PubMed
  44. Khalil S, Challener DW, Abu-Saleh O, Sohail MR. Laryngeal histoplasmosis in a kidney transplant recipient. Transpl Infect Dis. 2019 Aug; 21 (4):e13102 Epub 2019 May 22
    View PubMed
  45. Fida M, Challener D, Hamdi A, O'horo J, Abu Saleh O. Babesiosis: A Retrospective Review of 38 Cases in the Upper Midwest. Open Forum Infect Dis. 2019 Jul 1; 6 (7)
    View PubMed
  46. Challener DW, Prokop LJ, Abu-Saleh O. The Proliferation of Reports on Clinical Scoring Systems: Issues About Uptake and Clinical Utility. JAMA. 2019 Jun 25; 321 (24):2405-2406
    View PubMed
  47. Challener D, Abu Saleh O. A Traveler's Unwanted Souvenir. Am J Med. 2018 Apr; 131 (4):e137-e138 Epub 2017 Oct 12
    View PubMed
  48. Challener D, Abu Saleh O. Disseminated blastomycosis in a transplant patient. Transpl Infect Dis. 2018 Apr; 20 (2):e12870 Epub 2018 Mar 25
    View PubMed
  49. Challener D, Marcelin J, Visscher S, Baddour L. Hospital costs for patients with lower extremity cellulitis: a retrospective population-based study. Hosp Pract (1995). 2017 Dec; 45 (5):196-200 Epub 2017 Sept 27
    View PubMed
  50. Challener DW, Saleh OA, Whitaker JA. 58-Year-Old Woman With Diarrhea, Weakness, and Memory Loss. Mayo Clin Proc. 2017 Nov; 92 (11):1706-1710 Epub 2017 Sept 13
    View PubMed
  51. Marcelin JR, Challener DW, Tan EM, Lahr BD, Baddour LM. Incidence and Effects of Seasonality on Nonpurulent Lower Extremity Cellulitis After the Emergence of Community-Acquired Methicillin-Resistant Staphylococcus aureus. Mayo Clin Proc. 2017 Aug; 92 (8):1227-1233 Epub 2017 July 08
    View PubMed
  52. DeSimone DC, El Rafei A, Challener DW, Carr AB, Kelly JA, Rocca WA, St Sauver JL, Bock-Goodner CM, Lahr BD, Steckelberg JM, Wilson WR, Baddour LM. Effect of the American Heart Association 2007 Guidelines on the Practice of Dental Prophylaxis for the Prevention of Infective Endocarditis in Olmsted County, Minnesota. Mayo Clin Proc. 2017 May 10 [Epub ahead of print]
    View PubMed
PST-20517074